Jilin Province Huinan Changlong Bio-Pharmacy Company Limited (8049) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Company Snapshot

Business Description:

Jilin Province Huinan Changlong Bio-Pharmacy Company Limited operates in the Pharmaceutical preparations sector. Jilin Province Huinan Changlong Bio-Pharmacy Company Limited is principally engaged in the manufacture and distribution of biochemical medicines in the People's Republic of China under the brand names of Changlong and Shendi. The Company's subsidiaries include Jilin Province Huinan Changlong Pharmacy Trading Company Limited, which is engaged in trading of biochemical medicine, and Jilin Province Medicinal Plants Trading Company Limited. On October 19, 2010, the Company disposed its wholly owned subsidiary of Changlong Bio-Pharmacy (Hong Kong) Company Limited. On December 22, 2010, the Company established a subsidiary, in the People's Republic of China with 100% equity interest. In our complete report available for purchase the company is compared to: Lee's Pharmaceutical Holdings Ltd, Anxin-China Holdings Limited and Asia Resources Holdings Limited.

Jilin Province Huinan Changlong Bio-Pharmacy Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): .74
(Figures in Chinese Renmimbi)

1 Week	6.5%	13 Weeks	28.2%

4 Weeks	14.7%	52 Weeks	-23.6%

Jilin Province Huinan Changlong Bio-Pharmacy Company Limited Key Data:

Ticker:	8049	Country:	HONG KONG

Exchanges:	HKG	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	200,630,000 (Year Ending Jan 2011).	Employees:	406

Currency:	Chinese Renmimbi	Market Cap:	414,316,080

Fiscal Yr Ends:	December	Shares Outstanding:	560,250,000

Share Type:	H Gu	Closely Held Shares:	227,427,000

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.